Skip to content

Biofeedback-based Relaxation Training or Self-alert Training to Alleviate Fatigue in Multiple Sclerosis Patients.

Biofeedback-based Relaxation Training or Self-alert Training to Alleviate Fatigue in Multiple Sclerosis Patients.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03268187
Enrollment
61
Registered
2017-08-31
Start date
2017-07-17
Completion date
2018-10-18
Last updated
2019-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, Multiple Sclerosis

Keywords

Cognitive Fatigue, Multiple Sclerosis, Biofeedback, Self-Alert Training, Vigilance, Autonomic potentials

Brief summary

The presented study compares the effectiveness of a biofeedback-based relaxation training with the effectiveness of a biofeedback-based self-alert training on the reduction of fatigue in multiple sclerosis patients using a between groups design. Furthermore, the relation of fatigue in multiple sclerosis patients and autonomic potentials as well as the performance in a vigilance task will be examined. The relaxation training is based on the principle of progressive muscle relaxation according to Jacobsen. The patient is asked to tense all muscles in their face and perceive consciously the relaxation afterwards according to verbal cues. In the self-alert training condition, the patient will hear verbal cues to increase their attention. In both conditions the external cues given will be reduced in four phases until the patient has to cue himself. The patient is advised to track the changes in the skin resistance mirrored by biofeedback on a screen. In both conditions the training will be split on two days. During the whole examination heart rate and skin resistance will be recorded. The allocation to the training happens randomly. On the first day the patient will complete questionnaires to survey depression and apathy and do a baseline vigilance task. Before and after the vigilance task the current fatigue status will be assessed using a visual analogue scale. Afterwards an introduction in the treatment method will be given. On the second day the introduction into the training will be repeated. Afterwards a short time vigilance task will be done and questionnaires to survey fatigue and sleep behaviour and quality will be completed. Subsequently the last part of the training (no external cues) will be done. The examination will be completed by a long-time vigilance task. Before and after the vigilance task the current fatigue status will be assessed using a visual analogue scale. It is hypothesised that especially the biofeedback-based self-alert training has a positive effect on fatigue and the vigilance performance in multiple sclerosis patients, as it increases the ectodermal activity and increases the sympathetic activation. It was shown that phasic changes of the skin resistance are correlated with an increase of neuronal activity in the brain areas relevant for vigilance (Critchley et al., 2002; Nagai et al., 2004). The relaxation training will reduce the sympatho-adrenergic excitation disposition and reduce the level of activity. Consequently, we do not expect an alleviation of the perceived fatigue according to our underlying model (Hanken et al., 2016). In addition, it is hypothesized that, independent from the treatment, autonomic potentials correlate with fatigue.

Interventions

DEVICEBiofeedback

The skin conductance of the patient is measured and fed back to the patient via screen.

BEHAVIORALSelf-Alert Training

Self-Alert Training

BEHAVIORALRelaxation Training

Relaxation Training

Sponsors

Rehazentrum Wilhelmshaven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* at least a moderate cognitive fatigue (Fatigue Scale for Motor and Cognition minimum 22) * clinical diagnosis of Multiple Sclerosis

Exclusion criteria

* psychiatric conditions independent from Multiple Sclerosis * Pregnancy * regular intake of psychostimulants * no relapse in the last four weeks before * no cortisone therapy in the last four weeks before * patients with schizophrenia or serious personality disorders

Design outcomes

Primary

MeasureTime frameDescription
Reaction Time of Vigilance Task (TAP)Vigilance is measured at the beginning of the first day before the training introduction as well as after the training at the second day.Changes of the reaction time in the vigilance task
Subjective Fatigue (VAS)Before and after the long-term vigilance tasks at day 1 and 2The current perceived fatigue

Secondary

MeasureTime frameDescription
Omissions and errors of Vigilance Task (TAP)At day one before the introduction in the training and at day two after the training.The number of omissions and errors made in the Vigilance Task

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026